Fredun Pharma

71
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
2,384.10
-144.75 (-5.72%)
BSENSE

May 25

BSE+NSE Vol: 38.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 30.35% vs 26.75% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 38.61% vs 36.74% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 63.93% vs 47.07% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 33.18% vs 44.57% in Mar 2024

Compare Profit and Loss Results of Fredun Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
453.00
268.00
185.00
69.03%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
453.00
268.00
185.00
69.03%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
-2.00
8.00
400.00%
Raw Materials Consumed
321.00
98.00
223.00
227.55%
Power & Fuel Cost
4.00
0.00
4.00
0%
Employee Cost
22.00
70.00
-48.00
-68.57%
Operating Expenses
14.00
0.00
14.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
24.00
-19.00
-79.17%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
0.00
2.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
401.00
217.00
184.00
84.79%
Operating Profit (PBDIT) excl Other Income
52.00
51.00
1.00
1.96%
Other Income
2.00
8.00
-6.00
-75.00%
Operating Profit (PBDIT)
55.00
59.00
-4.00
-6.78%
Interest
22.00
0.00
22.00
0%
Profit before Depriciation and Tax
32.00
58.00
-26.00
-44.83%
Depreciation
4.00
8.00
-4.00
-50.00%
Profit Before Taxation & Exceptional Items
28.00
50.00
-22.00
-44.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
28.00
69.00
-41.00
-59.42%
Provision for Tax
7.00
14.00
-7.00
-50.00%
Profit After Tax
20.00
55.00
-35.00
-63.64%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
43.00
104.00
-61.00
-58.65%
Profit Available for appropriations
64.00
159.00
-95.00
-59.75%
Appropriations
64.00
159.00
-95.00
-59.75%
Equity Dividend (%)
7%
125%
-118.00
Earnings Per Share
44.83
8.26
36.57
442.74%
Profit And Loss - Net Sales
Net Sales 453.82 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.35% vs 26.75% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 52.65 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 38.61% vs 36.74% in Mar 2024

Profit And Loss - Interest
Interest 22.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 63.93% vs 47.07% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 20.81 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 33.18% vs 44.57% in Mar 2024